Jan.17 -- Jason Wu, chairman and chief executive officer at Ascletis Pharma, discusses the company's performance since the IPO, their new drugs coming to market, competition in the industry, regulatory approvals, drug prices, revenue targets and what drugs he's most excited about. He speaks on "Bloomberg Markets: Asia."...